Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Lilly patent describes prostanoid EP4 receptor antagonists

Nov. 28, 2014

Small-molecule MIF inhibitors tested in the collagen-induced arthritis mouse model

Nov. 25, 2014

CHMP backs Otezla for psoriasis and psoriatic arthritis

Nov. 24, 2014

Activity of novel PEGylated anti-IL-17A aptamer tested in models of rheumatoid arthritis

Nov. 21, 2014

Janssen files MAA for Simponi in severe active non-radiographic axial spondyloarthritis

Nov. 20, 2014

Clinical benefit on rheumatoid arthritis demonstrated in phase I trial of FPA-008

Nov. 20, 2014

Preclinical pharmacology, safety and activity profiling of dual JAK3/ITK inhibitor ARN-4079

Nov. 19, 2014

Chong Kun Dang Holdings patent divulges novel HDAC6 inhibitors

Nov. 19, 2014

INV-17 demonstrates safety and therapeutic activity in a model of rheumatoid arthritis

Nov. 17, 2014

R-Pharm CJSC discloses new B7 ligands/CD20 inhibitors

Nov. 4, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...